T he renin-angiotensin system (RAS) plays an essential role in blood pressure (BP) homeostasis and arterial hypertension. Two constituents of this hormonal cascade, renin and aldosterone, are frequently measured for diagnostic purposes. Their absolute concentrations and interrelations help in identifying causal hypertension mechanisms and may guide therapy. Primary hyperaldosteronism (PH), a well-known cause of secondary hypertension, clearly illustrates the effects of RAS dysregulation on hemodynamic and biochemical parameters. In PH, autonomous aldosterone secretion by the adrenals induces, among other things, arterial hypertension and hypokalemia. Its prevalence in hypertensives is estimated to be between 5% and 12%. 1 Although it can be treated with some success with drugs, surgery can, in certain cases, cure this disease and its clinical manifestations. The diagnosis relies on clinical flair at first, but then needs to be supported and confirmed by laboratory measurements.
A high aldosterone-to-renin ratio (ARR) reflects autonomous aldosterone secretion in PH and is the most frequently used screening test. Its sensitivity, specificity, and predictive value have been repeatedly evaluated with wide ranging results. 2 The main reason for this variability may lie in the influence of physiologic or pharmacologic factors on renin and aldosterone secretion and their interrelation. Antihypertensive drugs, posture, and hormonal diurnal cycles have been suspected of having such effects. Antihypertensive drugs are known to influence the RAS, and they may have significant actions on renin-aldoste-rone interrelations; but the measurement of the ARR is often carried out in the assumption that these therapies do not affect its predictive value. 3 Posture has a significant impact on plasma renin and aldosterone concentrations, but it is not clear whether the ARR is altered. It is common practice to measure the ARR in an ambulatory setting with unstandardized procedures. No firm recommendations have been made in this regard. Daily cycles of renin and aldosterone secretion have been demonstrated in humans. 4, 5 Both decrease at night and increase in the morning hours. It is presently unclear whether and how reninaldosterone interrelations vary during the day.
The study objectives were to measure the 24-h variations of renin, aldosterone, and the ARR in essential hypertensive patients and to assess the influence of posture, angiotensin receptor antagonists, calcium channel blockers, and angiotensin-converting enzyme (ACE) inhibitors on these parameters.
Methods

Study Population and Design
This substudy is part of a prospective, multicenter, openlabel, randomized, parallel-designed clinical trial. The main inclusion criteria were: stage I or II essential arterial hypertension (diastolic BP Ն 95 mm Hg and Յ 109 mm Hg), age between 40 and 75 years, the absence of significant cardiac, renal, pulmonary disease, and of pharmacologically treated diabetes. Patients were recruited in four study centers. The ethics committees of all four centers approved the protocol, and all patients signed consent forms before study inclusion.
Patients were taken off all previous antihypertensive drugs and given placebo daily for 4 weeks. The first 24-h study day (baseline) was performed at the end of this period, followed by randomization to amlodipine (5 mg once daily titrated to 10 mg once daily after 4 weeks), ramipril (2.5 mg once daily titrated to 10 mg once daily during 4 weeks) or telmisartan (80 mg once daily). The active treatment periods were 8 weeks, at the end of which a second 24-h study day was performed. Study days started with fasting patients arriving around 7:30 AM. Patients were given the study drug at 8 AM in a supine position. Patients remained on site for 24 h and had to be supine for at least 30 min before each measurement. Blood pressure and heart rate (HR) measurements were performed every 4 h from drug intake to the next morning. Blood was sampled simultaneously for renin, aldosterone, and norepinephrine at similar times. A 10-min postural challenge was performed at 9 AM, at the end of the study day. Blood pressure, renin, aldosterone, and norepinephrine were measured before and at the end of the standing posture.
Measurements
Blood pressure and HR were measured manually for patient inclusion and afterward with an automatic oscillometric BP monitor (SpaceLabs Inc. Model 90207-31, Redman, WA). Three or four measurements were averaged for better precision. The BP measured simultaneously to blood sampling served to assess interrelations between parameters. Plasma samples were frozen and measurements performed at the study end. Plasma renin and aldosterone were measured by radioimmunoassay (BIO-RAD 79986 Kit, Marnes La Coquette, France, and DSL-8600 ACTIVE, Webster, TX) with sensitivity limits of 1.00 ng/L and 21.2 pmol/L for renin and aldosterone, respectively. Catecholamines were measured by HPLC with a modified technique as described by Hjemdahl. 
Statistical Analysis
Three study subjects (SC102, SC104, SC106) had renin values too low for precise measurements (Ͻ 1.0 ng/L). Another subject (SC118) had plasma aldosterone values that were repeatedly and clearly above normal. Considering the importance of these two parameters and their interrelations in this study, these patients were excluded from the analyses.
Generalized estimating equations were used for baseline assessment of the linear association between variables measured during 24 h. Single point-in-time comparisons between treatment groups were made by one-way analysis of variance (ANOVA) and two points-in-time comparisons within treatment group by paired t tests. Repeatedmeasure ANOVA assessed the time and drug influence on 24-h measurements at baseline and after drug treatment. Assumptions for ANOVA (homogeneity of variance and normality) and t tests (normal distribution) were verified for each variable. Pearson correlation coefficients were used to measure associations between continuous variables at a single point in time. P Ͻ .05 was considered significant. The data were analyzed by StatView (SAS Institute Inc., Cary, NC) and SAS softwares (SAS Inc., Cary, NC).
Areas under the curve (AUC) versus time were calculated according to the trapezoidal rule. All results in the article were expressed as averages with standard deviations, with exceptions made for times to peaks and lows of a parameter during the circadian rhythm, which were expressed as modes. The ARR units are (in picomoles per liter per nanogram per dediliter) and are not repeated throughout the article for simplification.
Results
Population
Fifty-seven hypertensive patients were randomized: 22 to amlodipine, 17 to ramipril, and 18 to telmisartan ( Table 1 ). The patients were mostly white, middle-aged men with stage 1 or 2 hypertension. There were no significant demographic differences between groups. (Fig. 1 ). At baseline, morning systolic BP but not diastolic BP was significantly higher in the ramipril group than in the amlodipine and telmisartan groups. All patients were titrated to the highest study dose. Amlodipine's (Ϫ14.5 Ϯ 8.0/Ϫ8.6 Ϯ 6.3 mm Hg) and telmisartan's (Ϫ9.7 Ϯ 8.0/Ϫ6.3 Ϯ 4.1 mm Hg) 24-h average decrease in BP were clinically and statistically significant. Ramipril's antihypertensive efficacy only lasted 6 to 8 h and 24-h average decrease in BP (Ϫ3.6 Ϯ 11.7/Ϫ1.1 Ϯ 5.4 mm Hg) was statistically nonsignificant. Amlodipine, telmisartan, and ramipril had no significant effect on HR. Upright posture had no significant influence on BP at baseline (Ϫ7.0 Ϯ 22.9/Ϫ0.3 Ϯ 16.8 mm Hg) but significantly increased HR (ϩ10.4 Ϯ 8.9 beats/min).
Renin and Aldosterone
With all patient results averaged at baseline (n ϭ 53), morning renin and aldosterone concentrations were 2.14 Ϯ 1.33 ng/L and 226.6 Ϯ 93.1 pmol/L, respectively. There were clear renin circadian variations (P ϭ .003) with a low of 1.81 Ϯ 1.03 ng/L at 8 AM and a morning peak of 3.85 Ϯ 3.02 ng/L at noon (Fig. 2) . Aldosterone circadian variations were also present (P Ͻ 
Presented results are means Ϯ standard deviation.
FIG. 1
Average circadian blood pressure at baseline and with therapy. Average decrease in systolic and diastolic blood pressure with therapy.
.0001) with a night low of 124.3 Ϯ 45.6 pmol/L at midnight and a morning peak of 289.1 Ϯ 115.6 pmol/L at noon (Fig. 3 ). Renin (P ϭ .01) but not aldosterone concentrations were greater at the beginning of the circadian cycle than at the end. The lowest aldosterone levels preceded the lowest renin levels in 30 (57%) subjects. Peak aldosterone levels preceded peak renin levels in 23 (43%) subjects. At various time points throughout the circadian cycle, telmisartan and amlodipine significantly increased renin and ramipril tended to do so (Table 2, Fig. 2 ). Telmisartan (ϩ185.97 Ϯ 206.08 ng/h/L, P ϭ .002), ramipril (ϩ110.06 Ϯ 191.73 ng/h/L, P ϭ .046), and amlodipine (ϩ86.70 Ϯ 106.24 ng/h/L, P ϭ .001) significantly increased renin's AUC 0 -24 h . Telmisartan tended to increase renin more than amlodipine and ramipril during the 24-h period, but this was not statistically significant. Four hours postdose, aldosterone was increased by amlodipine and decreased by ramipril and telmisartan, but drug influences at other time points were usually not statistically significant ( Table 2, and on aldosterone levels 4 h postdose were statistically different from amlodipine's.
As expected, 10 min of upright posture at baseline significantly increased renin (ϩ1.05 Ϯ 2.47 ng/L, P Ͻ .0001) and aldosterone (ϩ26.5 Ϯ 28.0 ng/L, P Ͻ .0001) levels (Fig. 4) .
A statistically significant linear association was found at baseline between 24-h plasma renin and 24-h plasma norepinephrine (P ϭ .023) and aldosterone (P ϭ .049). Baseline aldosterone and norepinephrine 24-h circadian cycles were similar on visual inspection. Accordingly, a highly significant linear association (P Ͻ .0001) was found with a generalized estimating equation during 24 h. Twenty-four-hour plasma aldosterone levels were also linearly associated with 24-h systolic BP (P ϭ .0018) and diastolic BP (P ϭ .005).
Aldosterone-to-Renin Ratio
Baseline morning ARR was 134.3 Ϯ 72.8. A clear circadian variation of the ARR was confirmed by repeated-measures ANOVA (P Ͻ .0001) with minimum levels averaging 60.9 Ϯ 37.3 at ex aequo modes of 8 PM and midnight and maximum levels averaging 155.7 Ϯ 78.4 at a mode of 8 AM. All study drugs, but especially telmisartan, decreased the ARR throughout the circadian rhythm (Table 2, Fig. 5 ). Ramipril had a very significant effect 4 h postdose but less thereafter. Upright posture induced a statistically nonsignificant increase in the ARR from 131.5 Ϯ 70.6 to 151.6 Ϯ 122.1 (ϩ20.0 Ϯ 84.8) (Fig. 4) .
No association could be found between demographic factors (age, sex, race, weight, smoking, plasma potassium, creatinine) and the ARR. Although 24-h circadian variations of the ARR had a similar timeline to those of the hemodynamic parameters and norepinephrine, no significant correlations were found between these variables.
Implications of Circadian
Variations, Posture, and Drug Therapy on Screening "Positivity"
Cutoff values above which a result was considered to be indicative of primary hyperaldosteronism (positive results) were 140 and 416 pmol/L for the ARR and plasma aldosterone, respectively. 1, 7, 8 The ARR was "positive" in 36.5%, 28.3%, 25.0%, 13.5%, 2.0%, and 30.0% at 8 AM, noon, 4 PM, 8 AM, midnight, and 4 AM, respectively ( Table 3) . Both the ARR and aldosterone were over the cutoff value in 1.9%, 3.8%, 4.2%, 0%, 3.8%, and 4% at 8 AM, noon, 4 PM, 8 PM, midnight, and 4 AM, respectively. The 10-min stand increased the baseline ARR "positivity" from 36.5% to 48.8%, and the percentage of patients with "positive" ARR and aldosterone values from 1.3% to 16.3%. Amlodipine, ramipril, and telmisartan ANOVA calculations: P Ͻ .05 v # amlodipine; *Ramipril; P Ͻ .01 v ## amlodipine, **Ramipril; P Ͻ .001 v ### amlodipine, ***Ramipril. Calculations were performed after exclusion of 4 subjects (SC106, SC102, SC118, SC104) from the amlodipine (1), ramipril (2), and telmisartan (1) groups. Presented results are means Ϯ standard deviation.
decreased the percentage of subjects with an ARR Ͼ140. The same effects tended to occur when considering both ARR and plasma aldosterone criteria, but because of low baseline "positivity," this was not as evident.
Discussion
As expected, circadian variations of plasma renin and aldosterone concentrations were observed. The variations of aldosterone were more pronounced with a different timing for lows and peaks compared to renin. These differences generated a clinically significant circadian variation of the ARR. An ACE inhibitor, a dihydropyridinetype calcium channel blocker, and an angiotensin II receptor blocker were found to decrease the ARR with both statistical and clinical significance. Although the ARR increase after a 10-min stand was not statistically significant, the magnitude of the change suggests that posture may be important for screening purposes. Surprisingly, a high proportion of our patients had an ARR over the cutoff value of 140.
Renin
Circadian variations in plasma renin concentrations were shown in this study. These variations are believed to be due to changes in sympathetically mediated ␤1 stimulation 9 but single time-point correlations between renin and norepinephrine could not be found, and a linear association was barely found when the entire 24-h data were considered. The absence of a strong association could be explained by the exogenous influences of meal-related salt intake, which have a greater effect on renin secretion than on norepinephrine release. 10 -12 It could also be explained by a time lag between sympathetic tone variation and renin secretion modulation that was not accounted for by the simultaneous measurements of all parameters. Mean renin concentration was lower at the end of the study day than at its beginning, although both measurements were made at 8 AM. We believe this difference is explained by the prolonged supine periods intrinsic to the protocol procedure. Overall plasma renin concentrations were low throughout the study. A very high salt intake would be a plausible explanation, but diet was not monitored and sodium excretion was not measured. The short-lived antihypertensive effects of ramipril tend to confirm a salt repleted state. A high-salt low-renin environment may have increased the variation coefficient of renin measurements and may have masked associations that could have been evident in a low-salt environment.
Aldosterone
In this study we observed very significant circadian variations of plasma aldosterone. The timeline similarities between the observed 24-h plasma aldosterone cycle and the well-known cortisol cycle suggest common adrenocorticotropic hormone (ACTH)-mediated regulation. This is also suggested by past studies in which dexamethasone altered or abolished the aldosterone circadian cycle. [13] [14] [15] A positive relationship between plasma aldosterone and plasma norepinephrine was found in this study, but the physiologic link between them is unclear. Short-term norepinephrine infusion can increase aldosterone, 16 but there are little other data to suggest a direct influence of catecholamines on aldosterone secretion. [17] [18] [19] Aldosterone antagonism does not lower plasma norepinephrine levels, 20 and administration of fludrocortisone, a mineralocorticoid agonist, induces not an elevation but a diminution of plasma norepinephrine. 21 The aldosteronenorepinephrine association seen in this study most probably reflects common central nervous system influences.
Aldosterone and Renin Interrelations
In this investigation, aldosterone peaks and lows occurred before those of renin, suggesting that aldosterone secretion is not exclusively under RAS control. Past studies have suggested a greater influence of the hypothalamo-hypophyseal axis compared to the renin-angiotensin cascade on circadian aldosterone secretion, especially in salt-replete subjects. 13, 15, 22 It is well-known that upright posture activates the RAS but in this experiment, after a 10-min stand, the renin increase was proportionally lower than aldosterone's and no linear association could be found between them. This suggests either different and specific influences on each hormone, or a time lag between them that could not be accounted for by simultaneous measurements and a short standing period. A longer standing period could have strengthened the renin-aldosterone association and may have accentuated the observed ARR changes. 23 It would also have been a better reflection of the usual ambulatory care setting of patients.
Renin-aldosterone interrelations may not be constant in different salt-loading conditions, age increases the ARR by decreasing renin but not aldosterone, 24 and renin-aldosterone interrelations in normotensive individuals and in PH patients are not the same as in hypertensives. 2, 5 This study's results should therefore not be directly extrapolated to salt-depleted or PH patients and patients less than 40 years or more than 75 years of age.
Effect of Medication
Ramipril and telmisartan had the expected effects on renin and aldosterone because of their antihypertensive effects Calculations were performed after exclusion of 4 subjects (SC106, SC102, SC118, SC104) from the amlodipine (1), ramipril (2), and telmisartan (1) groups.
and their specific antagonism of the RAS. Interestingly, telmisartan's actions were more potent and of greater duration than ramipril's. Ramiprilat, the active metabolite of ramipril, has a short initial half-life but is known to have a long late-phase half-life and longlasting effects by binding very tightly to the ACE. 25 This study does not support the clinical importance of this late phase. Results could also be dose-related, and clinically significant effects could have lasted longer with the maximal recommended dose of ramipril (20 mg/d). Telmisartan and ramipril should be less potent in salt-repleted patients, 26, 27 but this experiment suggests that telmisartan may be less influenced by salt load. Amlodipine increased renin and aldosterone because of its effects on BP.
Calcium channel blockers, ACE inhibitors, and angiotensin II receptor blockers can decrease the ARR, 28, 29 and this has been confirmed in this study. It is frequently suggested that patients be taken off these drugs before measuring the ARR, but this is still being debated. 3 In our study, ramipril, telmisartan, and amlodipine significantly reduced the ARR. Telmisartan and ramipril did so by elevating renin and decreasing aldosterone, whereas amlodipine did so by increasing renin despite an increase in aldosterone. Of the three drugs used in this study, telmisartan clearly had the most significant effect on the ARR throughout the 24-h period. In recent clinical work comparing various drug classes, another angiotensin II receptor antagonist, irbesartan, induced the greatest decrease in the ARR, 29 which underlines the specificity of this drug class for the angiotensin II receptor, and its direct actions on the control mechanisms of renin release.
Influence of Posture, Circadian Rhythms, and Medication on ARR Screening Test
The ARR is usually measured with plasma renin activity, and there are little data on active renin. An ARR cutoff value (Ͼ140) using active renin concentration measurements was suggested recently by Lebel et al 7 and Racine et al. 8 In their studies, the ARR appeared to be the "main" criterion as no patients with essential hypertension had an "abnormally elevated" ARR. Interestingly, 36.5% of our study patients had a morning ARR Ͼ140, but only 2 subjects also had morning plasma aldosterone concentrations Ͼ 416 pmol/L. The reason for these differences appears to lie in the salt-repletion state of the patients. In the study by Lebel, the average morning renin and aldosterone concentrations were 18.8 ng/L and 344.7 pmol/L, respectively, whereas they were 2.14 ng/L and 228.0 pmol/L in our experiment. Aldosterone being proportionally less sensitive to salt loading than renin, 30 the ARR was "physiologically" increased. This study demonstrates the importance of a minimum aldosterone concentration for screening, and the importance of confirmatory tests for suspected PH. Captopril suppression tests were performed in all subjects with positive screening results in our study. All were negative.
Circadian rhythms of the ARR had clinically significant effects on the number of patients with values more than the cutoff point. These results suggest that renin and aldosterone measurements should be performed at a standard time, between 8 and 9 AM for better sensitivity and for practical purposes. Posture had a statistically nonsignificant effect on the ARR, but a 12% absolute increase in the number of patients with "positive" ARR may be clinically significant. This may even have been underestimated due to the short standing period. Amlodipine, ramipril, and, especially, telmisartan decreased the number of patients with morning ARR Ͼ140. These data suggest that angiotensin II receptor antagonists and perhaps ACE inhibitors and calcium channel blockers should be withheld before screening.
The data from this study cannot be extrapolated to patients with PH. It should be considered that patients with adrenal adenoma or primary hyperplasia have circadian cycles of aldosterone secretion, 14, 31 that patients with primary hyperplasia or adenomas are sensitive to angiotensin II, 32 and that adrenal adenomas are sensitive to ACTH. 32, 33 It is, therefore, probable that circadian rhythms and certain antihypertensive drugs have clinically significant influences on renin-aldosterone interrelations in PH patients.
In conclusion, the influence of circadian rhythms and antihypertensive drugs needs to be considered when using the ARR as a screening test for PH. Whenever possible, ACE inhibitors, calcium channel blockers, and especially angiotensin II receptor antagonists should be stopped before this test and blood should be sampled at standardized times. Posture may have a significant impact on the screening positivity rate. A minimum plasma aldosterone cutoff value is an essential adjunct to the ARR.
